Exenatide BID Improves β-Cell Function More than Liraglutide QD in Patients with Type 2 Diabetes: A Propensity Score Matched Retrospective Cohort Study (ELENA-β)

被引：0
|
作者：
Kondo, Yoshinobu
Satoh, Shinobu
Osada, Uru Nezu
Terauchi, Yasuo
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1155-P
引用
收藏
页码：A297 / A297
页数：1
相关论文
共 50 条
  • [1] Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study
    Kondo, Yoshinobu
    Satoh, Shinobu
    Osada, Uru Nezu
    Terauchi, Yasuo
    [J]. ENDOCRINE JOURNAL, 2015, 62 (11) : 971 - 980
  • [2] EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANY
    Miller, L. A.
    Burudpakdee, C.
    Zagar, A.
    Bhosle, M.
    Reaney, M.
    Schabert, V. F.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A103 - A104
  • [3] Real-World Adherence in Patients Aged=65 years with Type 2 Diabetes Mellitus for Exenatide QW, Liraglutide QD, and Exenatide BID
    Dufour, Robert
    Nguyen, Hiep
    Tarr, Amanda
    Bullano, Michael
    [J]. DIABETES, 2015, 64 : A294 - A295
  • [4] A Mobile-Based Intervention for Glycemic Control in Patients With Type 2 Diabetes: Retrospective, Propensity Score-Matched Cohort Study
    Li, Jing
    Sun, Li
    Wang, Yaogang
    Guo, Lichuan
    Li, Daiqing
    Liu, Chang
    Sun, Ning
    Xu, Zheng
    Li, Shu
    Jiang, Yunwen
    Wang, Yuan
    Zhang, Shunming
    Chen, Liming
    [J]. JMIR MHEALTH AND UHEALTH, 2020, 8 (03):
  • [5] Early Liraglutide Treatment Improves β-Cell Function in Patients With Type 2 Diabetes
    Kondo, Yoshinobu
    Satoh, Shinobu
    Inoue, Yuichiro
    Kimura, Masayo
    Hirama, Masayuki
    Nezu, Uru
    Terauchi, Yasuo
    [J]. DIABETES, 2013, 62 : A264 - A264
  • [6] Lower incidence of microvascular events associatedwith pioglitazone monotherapy than insulin monotherapy in patients with type 2 diabetes: A retrospective propensity score matched cohort analysis
    Rajagopalan, R
    Xu, Y
    Rosenson, R
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 336 - 337
  • [7] ADHERENCE: A REAL WORLD RETROSPECTIVE DATABASE STUDY AMONG TYPE 2 DIABETES PATIENTS TREATED WITH LIRAGLUTIDE OR EXENATIDE
    Maria, M.
    Carlqvist, P.
    Langer, J.
    Bouchard, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A503 - A503
  • [8] GLYCEMIC OUTCOMES AMONG PATIENTS RECEIVING EXENATIDE BID OR LIRAGLUTIDE FOR TYPE 2 DIABETES IN CLINICAL PRACTICE: A RETROSPECTIVE ANALYSIS OF THE GE CENTRICITY EMR DATA
    Best, J. H.
    Wintle, M.
    Saunders, W. B.
    DeYoung, M. B.
    Blickensderfer, A.
    Maggs, D.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A473 - A473
  • [9] Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
    Saunders, William B.
    Nguyen, Hiep
    Kalsekar, Iftekhar
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY, 2016, 9 : 217 - 223
  • [10] Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching
    Zhang, Yiyu
    Liu, Chaoyuan
    Luo, Shuoming
    Huang, Jin
    Yang, Yuxin
    Ma, Xiao
    Li, Xia
    Zhou, Zhiguang
    [J]. JMIR MHEALTH AND UHEALTH, 2021, 9 (02):
12345